PUBLIC COMPANY
saveMultitude therapeutics Inc
updated 2mo ago
community read0 votes
🐶 often sniffed alongside
top 3pipeline
1
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2AMT-116 in Combination With AK112 in Patients With Lung Cancer
- phase3Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
- EP1AMT-676 in Patients With Advanced Solid Tumors
- phase2A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
- phase2AMT-253 in Patients With Advanced Solid Tumours
- phase1AMT-116 in Patients With Advanced Solid Tumors
- phase2AMT-116 in Patients with Solid Tumors
- phase1AMT-151 in Patients With Selected Advanced Solid Tumours
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that